Yüklüyor......
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
Purpose: Pancreatic ductal adenocarcinoma (PDAC) with difficulty in early diagnosis does not respond well to conventional treatments and has not occurred significant improvement in the overall 5-year survival rates. Mesothelin (MSLN) is a tumor differentiation antigen expressed in several solid neop...
Kaydedildi:
| Yayımlandı: | Int J Med Sci |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ivyspring International Publisher
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053310/ https://ncbi.nlm.nih.gov/pubmed/32174772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.39012 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|